Healthcare provider profile · identity verified

Eneida Torres Alfonso, MD

General Practice · MIAMI, FL · NPI 1982133138

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	415	138
Pantoprazole Sodium	Pantoprazole Sodium	381	151
Gabapentin	Gabapentin	307	103
Losartan Potassium	Losartan Potassium	305	104
Metformin Hcl	Metformin Hcl	210	81
Rosuvastatin Calcium	Rosuvastatin Calcium	206	72
Amlodipine Besylate	Amlodipine Besylate	200	72
Azithromycin	Azithromycin	195	143
Levothyroxine Sodium	Levothyroxine Sodium	192	67
Omeprazole	Omeprazole	189	76
Clonazepam	Clonazepam	175	49
Famotidine	Famotidine	165	55
Baclofen	Baclofen	162	87
Metoprolol Succinate	Metoprolol Succinate	162	48
Ibuprofen	Ibuprofen	157	53
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	154	47
Alprazolam	Alprazolam	135	30
Lisinopril	Lisinopril	129	46
Meloxicam	Meloxicam	127	61
Montelukast Sodium	Montelukast Sodium	124	45
Hydrochlorothiazide	Hydrochlorothiazide	121	44
Tamsulosin Hcl	Tamsulosin Hcl	117	35
Ezetimibe	Ezetimibe	111	40
Albuterol Sulfate Hfa	Albuterol Sulfate	110	19
Sildenafil Citrate	Sildenafil Citrate	100	16
Folic Acid	Folic Acid	98	36
Escitalopram Oxalate	Escitalopram Oxalate	96	35
Triamcinolone Acetonide	Triamcinolone Acetonide	95	56
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	93	42
Meclizine Hcl	Meclizine Hcl	90	30
Metformin Hcl Er	Metformin Hcl	89	22
Methylprednisolone	Methylprednisolone	83	67
Lorazepam	Lorazepam	81	18
Clopidogrel	Clopidogrel Bisulfate	79	31
Ciprofloxacin Hcl	Ciprofloxacin Hcl	75	68
Vitamin D2	Ergocalciferol (Vitamin D2)	75	36
Dicyclomine Hcl	Dicyclomine Hcl	72	22
Temazepam	Temazepam	72	15
Glipizide	Glipizide	71	24
Ketoconazole	Ketoconazole	69	29
Ozempic	Semaglutide	69	14
Allopurinol	Allopurinol	67	17
Metoprolol Tartrate	Metoprolol Tartrate	67	22
Fenofibrate	Fenofibrate Nanocrystallized	65	31
Alendronate Sodium	Alendronate Sodium	64	22
Fluticasone Propionate	Fluticasone Propionate	64	17
Furosemide	Furosemide	64	21
Atenolol	Atenolol	61	19
Memantine Hcl	Memantine Hcl	60	19
Buspirone Hcl	Buspirone Hcl	59	12
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	54	17
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	52	24
Eliquis	Apixaban	51	16
Donepezil Hcl	Donepezil Hcl	50	22
Trazodone Hcl	Trazodone Hcl	50	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	12
Tadalafil	Tadalafil	49	suppressed
Trulicity	Dulaglutide	48	suppressed
Carvedilol	Carvedilol	47	16
Diclofenac Sodium	Diclofenac Sodium	46	18
Pregabalin	Pregabalin	46	suppressed
Ammonium Lactate	Ammonium Lactate	45	23
Glipizide Er	Glipizide	45	17
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	44	11
Paroxetine Hcl	Paroxetine Hcl	44	17
Quetiapine Fumarate	Quetiapine Fumarate	43	17
Sertraline Hcl	Sertraline Hcl	43	22
Bupropion Xl	Bupropion Hcl	41	16
Clonidine Hcl	Clonidine Hcl	41	16
Tizanidine Hcl	Tizanidine Hcl	41	29
Simvastatin	Simvastatin	40	12
Lactulose	Lactulose	39	21
Latanoprost	Latanoprost	39	suppressed
Mirtazapine	Mirtazapine	38	16
Naproxen	Naproxen	36	13
Nitrofurantoin	Nitrofurantoin Macrocrystal	36	28
Prednisone	Prednisone	36	30
Celecoxib	Celecoxib	35	15
Bumetanide	Bumetanide	33	14
Spironolactone	Spironolactone	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Nifedipine Er	Nifedipine	32	suppressed
Benzonatate	Benzonatate	31	25
Januvia	Sitagliptin Phosphate	30	12
Ciclopirox	Ciclopirox	28	12
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	26	25
Propranolol Hcl	Propranolol Hcl	26	suppressed
Diazepam	Diazepam	25	suppressed
Diclofenac Potassium	Diclofenac Potassium	25	11
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Mupirocin	Mupirocin	24	19
Xarelto	Rivaroxaban	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Levofloxacin	Levofloxacin	23	22
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Cilostazol	Cilostazol	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Hydrocortisone	Hydrocortisone	22	11
Nitroglycerin	Nitroglycerin	22	suppressed
Premarin	Estrogens, Conjugated	22	suppressed
Cephalexin	Cephalexin	20	14
Metronidazole	Metronidazole	20	18
Acyclovir	Acyclovir	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Fluconazole	Fluconazole	18	12
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Prednisolone Acetate	Prednisolone Acetate	18	15
Tramadol Hcl	Tramadol Hcl	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Valsartan	Valsartan	17	suppressed
Lubiprostone	Lubiprostone	16	suppressed
Nystatin	Nystatin	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	15	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Rhopressa	Netarsudil Mesylate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Finasteride	Finasteride	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Ciclopirox	Ciclopirox Olamine	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error